Nordion Inc (NDN.TO)

BUY
Favourite in the bio field.
TOP PICK
Great business with solid management and great vision.
BUY
Have good products/business. World class company.
BUY
Just bought. Health care is a good sector to be in now.
BUY
At a good price. Over the long term, it represents reasonable value.
BUY
Good time to buy. Will go up in a year.
BUY
Solid company. May be a good time to buy more.
TOP PICK
Good revenues with a 5 year target of 15% compounded yearly. Historically has met it's revenues forecast. Good assets.
WAIT
Following it closely. Still need to get the proteomics worked out. European operations are still weak. Earnings have been disappointing.
DON'T BUY
Good company. Stock got ahead of itself. Proteomics is a big drag on the stock. Burns a lot of cash.
HOLD
Would like to see the proteomics turn around so it doesn't use as much cash. Will be a slow move from here.
HOLD
Have suffered because of acquisitions. Will stay low for a year or two.
DON'T BUY
Have some good core business', but has other concerns. A little rich now. Prefers Biovale.
BUY
Good entry point for long term investment.
DON'T BUY
Earnings disappointing. Have to turn around European/proteomics problems. Good core business.
Showing 136 to 150 of 229 entries